Clinical data | |
---|---|
Pronunciation | /pəˈpævəriːn/ |
Trade names | Pavabid, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682707 |
Pregnancy category |
|
Routes of administration |
Oral, intravenous, intramuscular, rectal, intracavernosal |
ATC code | A03AD01 (WHO) G04BE02 (WHO) |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 80% |
Protein binding | ~90% |
Metabolism | Hepatic |
Biological half-life | 1.5–2 hours |
Excretion | Renal |
Identifiers | |
|
|
CAS Number |
58-74-2 61-25-6 (hydrochloride) |
PubChem (CID) | 4680 |
DrugBank | DB01113 |
ChemSpider | 4518 |
UNII | DAA13NKG2Q |
KEGG | D07425 |
ChEBI | CHEBI:28241 |
ChEMBL | CHEMBL19224 |
ECHA InfoCard | 100.000.361 |
Chemical and physical data | |
Formula | C20H21NO4 |
Molar mass | 339.385 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) |
Papaverine (Latin papaver, "poppy") is an opium alkaloid antispasmodic drug, used primarily in the treatment of visceral spasm, vasospasm (especially those involving the intestines, heart, or brain), and occasionally in the treatment of erectile dysfunction. It is used in the treatment of acute mesenteric ischemia. While it is found in the opium poppy, papaverine differs in both structure and pharmacological action from the analgesic (morphine-related) opium alkaloids (opiates).
Papaverine was discovered in 1848 by Georg Merck (1825–1873). Merck was a student of the German chemists Justus von Liebig and August Hofmann, and he was the son of Emanuel Merck (1794–1855), founder of the Merck corporation, a major German chemical and pharmaceutical company.
Papaverine is approved to treat spasms of the gastrointestinal tract, bile ducts and ureter and for use as a cerebral and coronary vasodilator in subarachnoid hemorrhage (combined with balloon angioplasty) and coronary artery bypass surgery. Papaverine may also be used as a smooth muscle relaxant in microsurgery where it is applied directly to blood vessels.